These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23351891)

  • 1. Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo.
    Zabihollahi R; Motevaseli E; Sadat SM; Azizi-Saraji AR; Asaadi-Dalaie S; Modarressi MH
    Daru; 2012 Oct; 20(1):53. PubMed ID: 23351891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models.
    Avitabile E; Menotti L; Giordani B; Croatti V; Parolin C; Vitali B
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effects of Lactobacillus crispatus against HSV-2 in mammalian cell lines.
    Mousavi E; Makvandi M; Teimoori A; Ataei A; Ghafari S; Samarbaf-Zadeh A
    J Chin Med Assoc; 2018 Mar; 81(3):262-267. PubMed ID: 29037754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal Lactobacilli Induce Differentiation of Monocytic Precursors Toward Langerhans-like Cells:
    Song J; Lang F; Zhao N; Guo Y; Zhang H
    Front Immunol; 2018; 9():2437. PubMed ID: 30410487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora.
    Verstraelen H; Verhelst R; Claeys G; De Backer E; Temmerman M; Vaneechoutte M
    BMC Microbiol; 2009 Jun; 9():116. PubMed ID: 19490622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Culture Supernatants of Lactobacillus gasseri and L. crispatus Inhibit Candida albicans Biofilm Formation and Adhesion to HeLa Cells.
    Matsuda Y; Cho O; Sugita T; Ogishima D; Takeda S
    Mycopathologia; 2018 Aug; 183(4):691-700. PubMed ID: 29603066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Potential Probiotic Lactobacilli for Prevention and Treatment of Vulvovaginal Infections.
    Kumherová M; Veselá K; Kosová M; Mašata J; Horáčková Š; Šmidrkal J
    Probiotics Antimicrob Proteins; 2021 Feb; 13(1):163-172. PubMed ID: 32583131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Inhibitory Effects of
    He Y; Niu X; Wang B; Na R; Xiao B; Yang H
    Front Med (Lausanne); 2020; 7():284. PubMed ID: 32637420
    [No Abstract]   [Full Text] [Related]  

  • 9. The in vitro anti-viral potential of Setarud (IMOD™), a commercial herbal medicine with protective activity against acquired immune deficiency syndrome in clinical trials.
    Zabihollahi R; Namazi R; Aghasadeghi MR; Esfahani AF; Sadat SM; Modarressi MH
    Indian J Pharmacol; 2012; 44(4):448-53. PubMed ID: 23087503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal Lactobacillus gasseri CMUL57 can inhibit herpes simplex type 2 but not Coxsackievirus B4E2.
    Kassaa IA; Hober D; Hamze M; Caloone D; Dewilde A; Chihib NE; Drider D
    Arch Microbiol; 2015 Jun; 197(5):657-64. PubMed ID: 25752765
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Parolin C; Frisco G; Foschi C; Giordani B; Salvo M; Vitali B; Marangoni A; Calonghi N
    Front Microbiol; 2018; 9():2630. PubMed ID: 30459737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of common vaginal Lactobacilli immunoreactive proteins by immunoproteomic techniques.
    Tooli LF; Shirzad M; Modarressi MH; Mirtavoos-Mahyari H; Amoozegar MA; Hantoushzadeh S; Motevaseli E
    World J Microbiol Biotechnol; 2019 Oct; 35(10):161. PubMed ID: 31608422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal Lactobacilli Reduce
    Foschi C; Salvo M; Cevenini R; Parolin C; Vitali B; Marangoni A
    Front Cell Infect Microbiol; 2017; 7():502. PubMed ID: 29270390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse Expression of Antimicrobial Activities Against Bacterial Vaginosis and Urinary Tract Infection Pathogens by Cervicovaginal Microbiota Strains of
    Atassi F; Pho Viet Ahn DL; Lievin-Le Moal V
    Front Microbiol; 2019; 10():2900. PubMed ID: 31921075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity.
    Parolin C; Marangoni A; Laghi L; Foschi C; Ñahui Palomino RA; Calonghi N; Cevenini R; Vitali B
    PLoS One; 2015; 10(6):e0131220. PubMed ID: 26098675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal
    Ñahui Palomino RA; Zicari S; Vanpouille C; Vitali B; Margolis L
    Front Microbiol; 2017; 8():906. PubMed ID: 28579980
    [No Abstract]   [Full Text] [Related]  

  • 17. Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues.
    Ñahui Palomino RA; Vanpouille C; Laghi L; Parolin C; Melikov K; Backlund P; Vitali B; Margolis L
    Nat Commun; 2019 Dec; 10(1):5656. PubMed ID: 31827089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of acidification in the inhibition of Neisseria gonorrhoeae by vaginal lactobacilli during anaerobic growth.
    Graver MA; Wade JJ
    Ann Clin Microbiol Antimicrob; 2011 Feb; 10():8. PubMed ID: 21329492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotic and Metabolic Characterization of Vaginal Lactobacilli for a Potential Use in Functional Foods.
    D'Alessandro M; Parolin C; Bukvicki D; Siroli L; Vitali B; De Angelis M; Lanciotti R; Patrignani F
    Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33919838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of detection methods for vaginal lactobacilli.
    Smidt I; Kiiker R; Oopkaup H; Lapp E; Rööp T; Truusalu K; Štšepetova J; Truu J; Mändar R
    Benef Microbes; 2015; 6(5):747-51. PubMed ID: 25869280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.